AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Luna InnovationsAnavex Life SciencesEloxx PharmaceuticalsPieris PharmaceuticalsSTARPHARMA HOLD/S
SymbolNASDAQ:LUNANASDAQ:AVXLOTCMKTS:ELOXNASDAQ:PIRSOTCMKTS:SPHRY
Price Information
Current Price$5.79$2.81$3.79$3.15$7.65
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$5.50$10.60$12.75$6.00N/A
% Upside from Price Target-5.01% downside277.22% upside236.41% upside90.48% upsideN/A
Trade Information
Market Cap$157.50 million$144.01 million$156.96 million$162.00 million$284.35 million
Beta0.712.27N/A1.271.5
Average Volume156,760391,09863,250505,7441,945
Sales & Book Value
Annual Revenue$42.92 millionN/AN/A$29.10 million$3.79 million
Price / Sales3.79N/AN/A5.3575.02
Cashflow$0.09 per shareN/AN/AN/AN/A
Price / Cash63.67N/AN/AN/AN/A
Book Value$2.23 per share$0.45 per shareN/A$0.74 per share$1.11 per share
Price / Book2.60N/AN/A4.266.89
Profitability
Net Income$11 million$-17,450,000.00N/A$-26,750,000.00$-7,970,000.00
EPS$0.04($0.39)N/A($0.50)N/A
Trailing P/E Ratio144.75N/A0.00N/A0.00
Forward P/E Ratio32.17N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins20.67%N/AN/A-147.19%N/A
Return on Equity (ROE)4.97%-151.39%N/A-114.25%N/A
Return on Assets (ROA)3.98%-118.27%N/A-28.79%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio3.74%5.03%N/A2.72%N/A
Quick Ratio3.06%5.03%N/A2.72%N/A
Ownership Information
Institutional Ownership Percentage24.01%22.34%N/A55.11%N/A
Insider Ownership Percentage11.20%12.30%44.03%6.59%N/A
Miscellaneous
Employees19613N/A107N/A
Shares Outstanding28.13 million52.65 million39.94 million49.39 million37.17 million
Next Earnings Date11/14/2019 (Estimated)12/11/2019 (Estimated)N/A11/6/2019 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable
 Luna InnovationsAnavex Life SciencesEloxx PharmaceuticalsPieris PharmaceuticalsSTARPHARMA HOLD/S

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel